Successful endovascular treatment of abdominal aortic rupture secondary to bacillus Calmette-Guérin vaccine.

Publication Title

J Vasc Surg Cases Innov Tech

Authors

Andrew E Liechty
Albert Pacifico, Division of Medicine, Section of Infectious Diseases, Providence Regional Medical Center Everett, Everett, WA, USAFollow
Peter Brant-Zawadzki, Division of Medicine, Section of Infectious Diseases, Providence Regional Medical Center Everett, Everett, WA, USAFollow

Document Type

Article

Publication Date

3-1-2022

Keywords

washington; everett; BCG vaccine; EVAR treatment; Infected graft; Mycotic pseudoaneurysm; Prophylaxis

Abstract

Bacillus Calmette-Guérin (BCG) vaccine has been successfully used to treat bladder cancer. However, sporadic cases of mycotic arterial aneurysms have been reported. These patients typically develop a Mycobacterium bovis infection of an existing aneurysm or graft. In the present report, we have described the case of a patient with a ruptured nonaneurysmal abdominal aorta years after intravesicular BCG therapy. Emergent aortic endograft repair was successful. After subsequent evaluation confirmed M. bovis infection, the patient was treated with a prolonged course of antimycobacterial therapy. Vascular surgeons should maintain suspicion for atypical aortic ruptures in patients with exposure to intravesicular BCG therapy.

Area of Special Interest

Cancer

Area of Special Interest

Cardiovascular (Heart)

Specialty/Research Institute

Oncology

Specialty/Research Institute

Cardiology

Specialty/Research Institute

Surgery